{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:45:14Z","timestamp":1790178314340,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T00:00:00Z","timestamp":1407801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.celrep.2014.08.017","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T18:23:11Z","timestamp":1410805391000},"page":"1870-1878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Thioredoxin and Its Reductase Are Present on Synaptic Vesicles, and Their Inhibition Prevents the Paralysis Induced by Botulinum Neurotoxins"],"prefix":"10.1016","volume":"8","author":[{"given":"Marco","family":"Pirazzini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Azarnia\u00a0Tehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aram","family":"Megighian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Scorzeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Fillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford\u00a0C.","family":"Shone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Binz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Rossetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florigio","family":"Lista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2014.08.017_bib1","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","article-title":"Long-distance retrograde effects of botulinum neurotoxin A","volume":"28","author":"Antonucci","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.celrep.2014.08.017_bib2","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0041-0101(01)00101-5","article-title":"A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice","volume":"39","author":"Aoki","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.celrep.2014.08.017_bib3","doi-asserted-by":"crossref","DOI":"10.3109\/00207454.2013.879581","article-title":"Effects of Ebselen on ischemia\/reperfusion injury in rat brain","author":"Aras","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.celrep.2014.08.017_bib4","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1046\/j.1432-1327.2000.01701.x","article-title":"Physiological functions of thioredoxin and thioredoxin reductase","volume":"267","author":"Arn\u00e9r","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.celrep.2014.08.017_bib5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10637-012-9846-2","article-title":"A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers","volume":"31","author":"Baker","year":"2013","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.celrep.2014.08.017_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbamcr.2008.02.003","article-title":"Thioredoxins and glutaredoxins as facilitators of protein folding","volume":"1783","author":"Berndt","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.celrep.2014.08.017_bib7","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1471-4159.2009.06093.x","article-title":"Cell entry strategy of clostridial neurotoxins","volume":"109","author":"Binz","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.celrep.2014.08.017_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2013.02.027","article-title":"Molecular profiling of synaptic vesicle docking sites reveals novel proteins but few differences between glutamatergic and GABAergic synapses","volume":"78","author":"Boyken","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2014.08.017_bib9","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0028-3908(95)00114-L","article-title":"Cysteine string protein, a DnaJ family member, is present on diverse secretory vesicles","volume":"34","author":"Braun","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.celrep.2014.08.017_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.toxicon.2013.05.004","article-title":"The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis","volume":"71","author":"Broide","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.celrep.2014.08.017_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.freeradbiomed.2011.10.447","article-title":"Small molecule inhibitors of mammalian thioredoxin reductase","volume":"52","author":"Cai","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.celrep.2014.08.017_bib12","first-page":"61083","article-title":"Possession, use, and transfer of select agents and toxins; biennial review. Final rule","volume":"77","year":"2012","journal-title":"Fed. Regist."},{"key":"10.1016\/j.celrep.2014.08.017_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12035-013-8423-9","article-title":"Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction","volume":"48","author":"Colasante","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.celrep.2014.08.017_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.tins.2005.06.001","article-title":"Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins","volume":"28","author":"Davletov","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.celrep.2014.08.017_bib15","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1083\/jcb.96.5.1355","article-title":"Synapsin I (Protein I), a nerve terminal-specific phosphoprotein. II. Its specific association with synaptic vesicles demonstrated by immunocytochemistry in agarose-embedded synaptosomes","volume":"96","author":"De Camilli","year":"1983","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.celrep.2014.08.017_bib16","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/prot.22952","article-title":"On the evolutionary origin of the chaperonins","volume":"79","author":"Dekker","year":"2011","journal-title":"Proteins"},{"key":"10.1016\/j.celrep.2014.08.017_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/307457a0","article-title":"Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization","volume":"307","author":"Dolly","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2014.08.017_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.mib.2012.05.012","article-title":"Clinical applications of botulinum toxin","volume":"15","author":"Dressler","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.celrep.2014.08.017_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(97)13448-6","article-title":"Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human","volume":"224","author":"Eleopra","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.celrep.2014.08.017_bib20","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1086\/597310","article-title":"Persistence of botulinum toxin in patients\u2019 serum: Alaska, 1959-2007","volume":"199","author":"Fagan","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2014.08.017_bib21","doi-asserted-by":"crossref","first-page":"25284","DOI":"10.1074\/jbc.M414645200","article-title":"Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity","volume":"280","author":"Fang","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2014.08.017_bib22","doi-asserted-by":"crossref","first-page":"29604","DOI":"10.1074\/jbc.M703619200","article-title":"Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes","volume":"282","author":"Fischer","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2014.08.017_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.toxicon.2013.01.007","article-title":"Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function","volume":"75","author":"Fischer","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.celrep.2014.08.017_bib24","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1523\/JNEUROSCI.13-11-04997.1993","article-title":"Relative properties and localizations of synaptic vesicle protein isoforms: the case of the synaptophysins","volume":"13","author":"Fykse","year":"1993","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.celrep.2014.08.017_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxicon.2012.12.004","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders","volume":"67","author":"Hallett","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.celrep.2014.08.017_bib26","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1089\/ars.2012.4599","article-title":"Thioredoxins, glutaredoxins, and peroxiredoxins\u2014molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling","volume":"19","author":"Hanschmann","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.celrep.2014.08.017_bib27","doi-asserted-by":"crossref","first-page":"35966","DOI":"10.1074\/jbc.M111.283879","article-title":"Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism","volume":"286","author":"Harper","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2014.08.017_bib28","first-page":"1","article-title":"Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes","volume":"364","author":"Hill","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.celrep.2014.08.017_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.bi.54.070185.001321","article-title":"Thioredoxin","volume":"54","author":"Holmgren","year":"1985","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.celrep.2014.08.017_bib30","doi-asserted-by":"crossref","first-page":"13963","DOI":"10.1016\/S0021-9258(18)71625-6","article-title":"Thioredoxin and glutaredoxin systems","volume":"264","author":"Holmgren","year":"1989","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2014.08.017_bib31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2010.03.083","article-title":"Thioredoxin and thioredoxin reductase: current research with special reference to human disease","volume":"396","author":"Holmgren","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2014.08.017_bib32","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.str.2013.06.020","article-title":"Conservation of protein structure over four billion years","volume":"21","author":"Ingles-Prieto","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.celrep.2014.08.017_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0072-9752(07)01511-4","article-title":"Botulism","volume":"91","author":"Johnson","year":"2008","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.celrep.2014.08.017_bib34","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0006-2952(97)00597-2","article-title":"Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides","volume":"55","author":"Kirkpatrick","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.celrep.2014.08.017_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jmb.2008.12.027","article-title":"Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation","volume":"386","author":"Kumaran","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.celrep.2014.08.017_bib36","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","article-title":"Crystal structure of botulinum neurotoxin type A and implications for toxicity","volume":"5","author":"Lacy","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.celrep.2014.08.017_bib37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1074\/jbc.R800045200","article-title":"Selenoproteins","volume":"284","author":"Lu","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2014.08.017_bib38","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1089\/ars.2012.4650","article-title":"Thioredoxin system in cell death progression","volume":"17","author":"Lu","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.celrep.2014.08.017_bib39","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1158\/0008-5472.CAN-05-3310","article-title":"Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity","volume":"66","author":"Lu","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2014.08.017_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10787-012-0149-1","article-title":"The biological activity of auranofin: implications for novel treatment of diseases","volume":"20","author":"Madeira","year":"2012","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.celrep.2014.08.017_bib41","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1089\/ars.2012.4757","article-title":"The thioredoxin system as a therapeutic target in human health and disease","volume":"19","author":"Mahmood","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.celrep.2014.08.017_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pharmtox-011613-135935","article-title":"Engineered botulinum neurotoxins as new therapeutics","volume":"54","author":"Masuyer","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.celrep.2014.08.017_bib43","doi-asserted-by":"crossref","first-page":"13310","DOI":"10.1073\/pnas.93.23.13310","article-title":"Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons","volume":"93","author":"Matteoli","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2014.08.017_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0378-4274(03)00090-0","article-title":"Potential renal and hepatic toxicity of diphenyl diselenide, diphenyl ditelluride and Ebselen for rats and mice","volume":"143","author":"Meotti","year":"2003","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.celrep.2014.08.017_bib45","first-page":"152","article-title":"Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions","volume":"84","author":"Molgo","year":"1990","journal-title":"J.\u00a0Physiol. (Paris)"},{"key":"10.1016\/j.celrep.2014.08.017_bib46","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","article-title":"Botulinum neurotoxin: a marvel of protein design","volume":"79","author":"Montal","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.celrep.2014.08.017_bib47","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coph.2004.12.006","article-title":"Botulinal neurotoxins: revival of an old killer","volume":"5","author":"Montecucco","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.celrep.2014.08.017_bib48","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1111\/j.1460-9568.2007.05529.x","article-title":"Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C","volume":"25","author":"Morbiato","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.celrep.2014.08.017_bib49","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1471-4159.2005.03506.x","article-title":"Immunoisolation of two synaptic vesicle pools from synaptosomes: a proteomics analysis","volume":"95","author":"Morciano","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.celrep.2014.08.017_bib50","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1471-4159.2008.05824.x","article-title":"The proteome of the presynaptic active zone: from docked synaptic vesicles to adhesion molecules and maxi-channels","volume":"108","author":"Morciano","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.celrep.2014.08.017_bib51","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1259\/bjr\/34180435","article-title":"The thioredoxin system: a key target in tumour and endothelial cells","volume":"81","author":"Mukherjee","year":"2008","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.celrep.2014.08.017_bib52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.toxicon.2012.10.020","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders","volume":"67","author":"Naumann","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.celrep.2014.08.017_bib53","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.tiv.2006.01.012","article-title":"Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1)","volume":"20","author":"Omata","year":"2006","journal-title":"Toxicol. In\u00a0Vitro"},{"key":"10.1016\/j.celrep.2014.08.017_bib54","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00018-013-1380-7","article-title":"The blockade of the neurotransmitter release apparatus by botulinum neurotoxins","volume":"71","author":"Pantano","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.celrep.2014.08.017_bib55","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.febslet.2012.11.007","article-title":"The thioredoxin reductase-thioredoxin system is involved in the entry of tetanus and botulinum neurotoxins in the cytosol of nerve terminals","volume":"587","author":"Pirazzini","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.celrep.2014.08.017_bib56","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.freeradbiomed.2010.12.015","article-title":"Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors","volume":"50","author":"Rackham","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.celrep.2014.08.017_bib57","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00280-010-1343-8","article-title":"A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination","volume":"67","author":"Ramanathan","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.celrep.2014.08.017_bib58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0076-6879(10)74007-6","article-title":"Mitochondrial thioredoxin reductase purification, inhibitor studies, and role in cell signaling","volume":"474","author":"Rigobello","year":"2010","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.celrep.2014.08.017_bib59","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1471-4159.2006.03965.x","article-title":"Presynaptic enzymatic neurotoxins","volume":"97","author":"Rossetto","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.celrep.2014.08.017_bib60","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: genetic, structural and mechanistic insights","volume":"12","author":"Rossetto","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.celrep.2014.08.017_bib61","first-page":"79","article-title":"Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats","volume":"38","author":"Rozell","year":"1985","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.celrep.2014.08.017_bib62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-5793(93)80448-4","article-title":"Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds","volume":"335","author":"Schiavo","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.celrep.2014.08.017_bib63","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1086\/592574","article-title":"International outbreak of severe botulism with prolonged toxemia caused by commercial carrot juice","volume":"47","author":"Sheth","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.celrep.2014.08.017_bib64","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuroscience.2005.11.040","article-title":"alpha-Neurexins are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction","volume":"138","author":"Sons","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.celrep.2014.08.017_bib65","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0006-8993(85)91421-0","article-title":"Axoplasmic transport of thioredoxin and thioredoxin reductase in rat sciatic nerve","volume":"359","author":"Stemme","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.celrep.2014.08.017_bib66","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cell.2006.10.030","article-title":"Molecular anatomy of a trafficking organelle","volume":"127","author":"Takamori","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2014.08.017_bib67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.STR.29.1.12","article-title":"Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial","volume":"29","author":"Yamaguchi","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.celrep.2014.08.017_bib68","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1073\/pnas.122061399","article-title":"Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant","volume":"99","author":"Zhao","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124714006809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124714006809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:32:52Z","timestamp":1761903172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124714006809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S2211124714006809"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2014.08.017","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thioredoxin and Its Reductase Are Present on Synaptic Vesicles, and Their Inhibition Prevents the Paralysis Induced by Botulinum Neurotoxins","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2014.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}